...
首页> 外文期刊>European journal of dermatology: EJD >In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.
【24h】

In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.

机译:伊曲康唑联合特比萘芬对伊曲康唑不敏感的施氏孢子虫临床菌株的体外活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Four strains of Sporothrix schenckii were isolated from patients with cutaneous sporotrichosis who failed itraconazole (ITC) treatment. To investigate the susceptibility of these strains to ITC and terbinafine (TRB) alone and in combination in 2 growth phases in vitro, a checkerboard microdilution method was used in accordance with the recommendations of the Clinical Laboratory Standards Institute (CLSI) was used in our study. The drug interaction was evaluated by assessing the fractional inhibitory concentration index (FICI). The geometric means (GMs) of the minimum inhibitory concentrations (MICs) of 4 insensitive strains were obviously higher than those of the sensitive isolates used for comparison. The FICI analysis revealed that only 2 isolates (25%) were synergistic in yeast form. Our results indicate the failure of clinical treatments might be caused by the insensitivity to ITC of these strains.
机译:从伊曲康唑(ITC)治疗失败的皮肤孢子虫病患者中分离出四株申氏孢子菌。为了研究这些菌株单独和联合在两个生长阶段对ITC和特比萘芬(TRB)的敏感性,我们根据临床实验室标准协会(CLSI)的建议使用了棋盘微稀释法。通过评估分数抑制浓度指数(FICI)来评估药物相互作用。 4种不敏感菌株的最低抑菌浓度(MIC)的几何平均值(GMs)明显高于用于比较的敏感菌株的几何平均值(GMs)。 FICI分析表明,只有2个分离株(25%)以酵母形式具有协同作用。我们的结果表明,临床治疗的失败可能是由于这些菌株对ITC的不敏感性所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号